INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

Pooled results from many studies on one question.

364 studies · page 7 of 16

2018 / Systematic review and meta-analysis of randomized controlled trials

Omega-3 intake showed little to no effect on cardiovascular mortality or events

A systematic review of 79 randomized trials including 112,059 adults assessed long-chain omega-3 and alpha-linolenic acid interventions. Increasing long-chain omega-3 had little or no effect on all-cause mortality (RR 0.98, 95% CI 0.90 to 1.03) or cardiovascular events (RR 0.99, 95% CI 0.94 to 1.04). Plant-based alpha-linolenic acid slightly reduced cardiovascular events (RR 0.95, 95% CI 0.83 to 1.07) and coronary mortality (RR 0.95, 95% CI 0.72 to 1.26) based on low-quality evidence.

Abdelhamid AS, Brown TJ, Brainard JS, et al. Cochrane Database Syst Rev, 2018. PMID 30019766

2018 / Meta-analysis of prospective cohorts

Both low and high carbohydrate intakes were associated with increased mortality risk.

In the ARIC cohort of 15,428 US adults followed for 25 years (6,283 deaths), carbohydrate intake showed a U-shaped association with mortality, with lowest risk at 50% to 55% of energy. A meta-analysis of eight prospective cohorts (432,179 participants, 40,181 deaths) confirmed higher mortality for intakes under 40% (HR 1.20, 95% CI 1.09-1.32) and over 70% (HR 1.23, 95% CI 1.11-1.36). Animal-based low-carbohydrate diets were linked to higher mortality, whereas plant-based substitutions were linked to lower mortality.

Shows an association, not proof of cause and effect.

Seidelmann SB, Claggett B, Cheng S, et al. Lancet Public Health, 2018. PMID 30122560

2018 / Secondary RCT analysis and meta-analysis of RCTs

Homocysteine-lowering treatment with B vitamins was not associated with the risk of fracture in an updated meta-analysis of randomized trials.

Researchers conducted a secondary analysis of the AFPPS trial (1,021 participants randomized to 1 mg/day folic acid or placebo) alongside an updated meta-analysis of six RCTs (36,527 participants) evaluating homocysteine-lowering B-vitamin treatment on fracture risk. In the AFPPS, folic acid was not significantly associated with any fracture (RR = 0.95; 95% CI 0.61-1.48) or hip fracture (RR = 0.98; 95% CI 0.25-3.89). In the meta-analysis, interventions with folic acid and/or vitamin B12 yielded a pooled RR of 0.97 (95% CI 0.87-1.09) for any fracture and 1.00 (95% CI 0.81-1.23) for hip fracture. The authors concluded that no association was found between homocysteine-lowering treatment with B vitamins and fracture risk.

Garcia Lopez M, Baron JA, Omsland TK, et al. JBMR Plus, 2018. PMID 30283911

2018 / Systematic review

A systematic review identified toxic agents, including selenium and vitamin A, linked to alopecia.

A systematic review of 47 studies from PubMed, EMBASE, and Cochrane assessed hair loss resulting from exposure to or ingestion of toxic agents. Agents with the strongest evidence of association with alopecia included thallium, mercury, selenium, and colchicine. Incidents were also described for boric acid, arsenic, vitamin A, botulinum toxin, Podostroma cornu-damae, and the synthetic opioid MT-45. The authors noted that the strength of evidence varies across agents, with newer or less-documented substances requiring further investigation.

Shows an association, not proof of cause and effect.

Yu V, Juhász M, Chiang A, et al. Skin Appendage Disord, 2018. PMID 30410891

2018 / Systematic review and meta-analysis

Lung cancer was linked to lower serum folate and vitamin B6 and higher homocysteine concentrations in a meta-analysis.

A systematic review and meta-analysis of 14 articles including 8,097 lung cancer patients examined serum one-carbon metabolism factors. Compared with controls, lung cancer patients had lower serum folate (SMD -0.53, 95% CI -0.70 to -0.35, p = 0.001) and vitamin B6 (SMD -0.28, 95% CI -0.53 to -0.02, p = 0.001), but higher homocysteine levels (SMD 0.41, 95% CI 0.24 to 0.59, p = 0.001). No significant differences were seen for vitamin B12 (SMD -0.09, 95% CI -0.27 to 0.09, p = 0.202) or methionine (SMD -0.13, 95% CI -0.36 to 0.10, p = 0.001).

Shows an association, not proof of cause and effect.

Yang J, Li H, Deng H, et al. Front Oncol, 2018. PMID 30430082

2018 / Systematic review and random-effects meta-analysis of RCTs

Protein supplementation did not significantly improve muscle mass, strength, or physical performance in nonfrail community-dwelling older adults.

A systematic review and random-effects meta-analysis of 36 randomized controlled trials evaluated the effects of protein supplementation in 1,682 nonfrail community-dwelling older adults. Protein supplementation showed no significant effects on lean body mass (SMD: 0.11; 95% CI: -0.06, 0.28), handgrip strength (SMD: 0.58; 95% CI: -0.08, 1.24), lower extremity muscle strength (SMD: 0.03; 95% CI: -0.20, 0.27), gait speed (SMD: 0.41; 95% CI: -0.04, 0.85), or chair-rise ability (SMD: 0.10; 95% CI: -0.08, 0.28) compared to control. No superior effects were observed during concomitant resistance exercise training. The authors noted habitual protein intake was already sufficient in most participants, and interventions varied by protein type, amount, and timing.

Ten Haaf DSM, Nuijten MAH, Maessen MFH, et al. Am J Clin Nutr, 2018. PMID 30475963

2018 / Systematic review and meta-analysis of randomized controlled trials

Increasing long-chain omega-3 intake has little or no effect on mortality or cardiovascular events, while plant-based ALA may slightly reduce cardiovascular events.

This systematic review assessed 79 RCTs evaluating increased long-chain omega-3 (LCn3) or alpha-linolenic acid (ALA) for cardiovascular outcomes. High-quality evidence showed little or no effect of LCn3 on all-cause mortality (RR 0.98, 95% CI 0.90 to 1.03) or cardiovascular events (RR 0.99, 95% CI 0.94 to 1.04), though LCn3 reduced triglycerides by ~15% in a dose-dependent manner. Increasing ALA probably made little difference to all-cause mortality (RR 1.01, 95% CI 0.84 to 1.20), but low-quality evidence suggested it may slightly reduce cardiovascular events (RR 0.95, 95% CI 0.83 to 1.07) and arrhythmia (RR 0.79, 95% CI 0.57 to 1.10).

Abdelhamid AS, Brown TJ, Brainard JS, et al. Cochrane Database Syst Rev, 2018. PMID 30521670

2018 / Systematic review

Lifestyle modifications including diet and supplements may help alleviate LUTS in men aged 50 and older, though rigorously designed evidence remains minimal.

A systematic review searched literature from 2000 through 2017 regarding the prevalence, burden, and management of lower urinary tract symptoms (LUTS) in men aged 50 and older. LUTS was estimated to affect 2.3 billion people globally in 2018, with 44.7% being men. Evidence suggests lifestyle modifications—including physical activity, dietary modification, nutritional supplements, and pelvic muscle exercises—can alleviate LUTS and improve quality of life. However, evidence based on rigorous methodology remains minimal and cannot be generalized, and evidence on the effectiveness of weight loss programs to reduce LUTS is inconclusive.

Zhang AY, Xu X SAGE Open Nurs, 2018. PMID 33415211

2017 / Meta-analysis of prospective cohorts

High saturated fat intake was associated with higher breast-cancer-specific mortality.

A meta-analysis evaluated 15 prospective cohort studies examining dietary fat intake and mortality among women with breast cancer. Total fat intake was not associated with breast-cancer-specific death (HR 1.14, 95% CI 0.86-1.52) or all-cause mortality (HR 1.73, 95% CI 0.82-3.66). However, the highest versus lowest intake of saturated fat was linked to higher breast-cancer-specific death (HR 1.51, 95% CI 1.09-2.09, p < 0.01).

Shows an association, not proof of cause and effect.

Brennan SF, Woodside JV, Lunny PM, et al. Crit Rev Food Sci Nutr, 2017. PMID 25692500

2017 / Systematic review and meta-analysis of observational studies

Vegetarian and vegan diets were linked to lower ischemic heart disease and cancer incidence.

A meta-analysis of 86 cross-sectional and 10 prospective cohort studies evaluated vegetarian and vegan diets against omnivorous diets. Prospective cohorts linked vegetarian diets to lower risk of ischemic heart disease incidence or mortality (RR 0.75, 95% CI 0.68 to 0.82) and total cancer incidence (RR 0.92, 95% CI 0.87 to 0.98), but found no link to all-cause or cardiovascular mortality. Vegan diets were associated with lower total cancer incidence (RR 0.85, 95% CI 0.75 to 0.95).

Shows an association, not proof of cause and effect.

Dinu M, Abbate R, Gensini GF, et al. Crit Rev Food Sci Nutr, 2017. PMID 26853923

2017 / Systematic review

A systematic review found that few studies on nutrition and acne meet high enough scientific standards to support clinical therapeutic recommendations.

This systematic review aimed to assess the availability and quality of systematic studies on nutrition and acne vulgaris. PubMed and Cochrane searches were conducted to identify studies examining dietary factors, categorizing evidence from level A (double-blind randomized study) to level D (expert opinion/case report). The review found that only a small proportion of studies met sufficiently high scientific standards to enable practical therapeutic recommendations.

Fiedler F, Stangl GI, Fiedler E, et al. Acta Derm Venereol, 2017. PMID 27136757

2017 / Systematic review

Special diets and supplements are widely used by youth with autism spectrum disorder.

A systematic review evaluated 20 studies with 9,540 participants regarding complementary and alternative medicine use in autism spectrum disorder. The prevalence of any alternative therapy use ranged from 28% to 95%, with a median of 54%. Dietary supplements, vitamins, and specialized diets represented the most frequent therapies, ranking highest in 75% of the reviewed studies.

Höfer J, Hoffmann F, Bachmann C Autism, 2017. PMID 27231337

2017 / Systematic review

Guidelines on sugar intake are supported by low-quality evidence and poor methodology.

A systematic review assessed nine public health guidelines containing 12 recommendations regarding dietary sugars. All guidelines recommended reducing nonintrinsic sugar intake, citing concerns including weight gain, dental caries, and nutrient displacement. However, the guidelines scored poorly on development rigor, applicability, and editorial independence according to AGREE II criteria, and supporting evidence was rated as low to very low quality using GRADE methodology.

Erickson J, Sadeghirad B, Lytvyn L, et al. Ann Intern Med, 2017. PMID 27992898

2017 / Meta-analysis of controlled feeding studies and narrative review

A meta-analysis of controlled feeding studies found lower-fat diets resulted in slightly greater energy expenditure and fat loss than lower-carbohydrate diets.

This review discusses body weight regulation, energy balance components, and diet composition. In a meta-analysis of 32 controlled feeding studies with isocaloric substitution of carbohydrate for fat, both energy expenditure (26 kcal/d; P < .0001) and fat loss (16 g/d; P < .0001) were greater with lower-fat diets. The authors also reviewed weight-loss resistance mechanisms, noting that the set-point model aligns best with current data.

Hall KD, Guo J Gastroenterology, 2017. PMID 28193517

2017 / Systematic review of randomized controlled trials

In older adults, exercise improves muscle mass and function, but adding nutritional supplementation provides limited additional benefit.

This systematic review updated prior evidence and included 37 RCTs evaluating combined exercise training and dietary supplementation in adults aged 60 and older. Exercise increased muscle mass in 79% of trials (27/34), muscle strength in 82.8% (29/35), and physical performance in 92.8% (26/28). However, an additional benefit from nutritional supplementation was observed in only 23.5% (8/34) of muscle mass studies, 22.8% (8/35) of strength studies, and 14.3% (4/28) of performance studies. The authors noted high heterogeneity across exercise and supplement protocols, and noted studies were mainly performed in well-nourished subjects.

Beaudart C, Dawson A, Shaw SC, et al. Osteoporos Int, 2017. PMID 28251287

2017 / Systematic review

A high-fat meal consistently raised postprandial interleukin-6 but not other inflammatory markers

A systematic review synthesized 47 studies assessing inflammatory responses for at least 2 hours after a single high-fat meal in healthy adults. Interleukin-6 was the only marker that changed consistently, doubling from roughly 1.4 pg/mL at baseline to peak at approximately 2.9 pg/mL around 6 hours postprandially. C-reactive protein, tumor necrosis factor alpha, interleukin-1beta, and interleukin-8 showed no significant changes in most trials.

Emerson SR, Kurti SP, Harms CA, et al. Adv Nutr, 2017. PMID 28298267

2017 / Systematic review and meta-analysis

Milk intake and IGF-I levels were positively associated with prostate cancer risk.

A systematic review evaluated 172 studies to assess whether milk intake influences prostate cancer via the insulin-like growth factor pathway. Moderate evidence indicated circulating IGF-I and IGFBP-3 increased with milk consumption. In meta-analyses, higher IGF-I was linked to increased prostate cancer risk (OR 1.09, 95% CI 1.03-1.16; 51 studies), while IGFBP-3 was linked to lower risk (OR 0.90, 95% CI 0.83-0.98; 39 studies).

Harrison S, Lennon R, Holly J, et al. Cancer Causes Control, 2017. PMID 28361446

2017 / Systematic review

A systematic review examined the conflicting evidence on the impact of vitamin K levels, intake, and supplementation on bone health and fractures.

Vitamin K is required for osteocalcin carboxylation and plays roles in bone metabolism, including promoting osteoblast-to-osteocyte transition and limiting osteoclastogenesis. Multiple observational and interventional studies have investigated the relationship between vitamin K and bone health, but findings have remained conflicting and unclear. This systematic review aims to examine how vitamin K plasma levels, dietary intake, and oral supplementation affect bone remodeling, bone mineral density, and fragility fractures.

Palermo A, Tuccinardi D, D'Onofrio L, et al. Metabolism, 2017. PMID 28403946

2017 / Meta-analysis of randomized controlled trials

Oral potassium supplementation modestly reduced blood pressure in adults with primary hypertension

A meta-analysis evaluated 23 randomized placebo-controlled trials encompassing 1,213 individuals with primary hypertension treated for at least 4 weeks. Potassium supplementation reduced systolic blood pressure by 4.25 mmHg (95% CI: -5.96 to -2.53) and diastolic blood pressure by 2.53 mmHg (95% CI: -4.05 to -1.02). The authors reported no significant adverse events associated with the intervention.

Poorolajal J, Zeraati F, Soltanian AR, et al. PLoS One, 2017. PMID 28419159

2017 / Systematic review and meta-analysis

Calorie restriction for at least twelve weeks was linked to reduced food cravings.

A meta-analysis of eight studies evaluated changes in food cravings after at least 12 weeks of calorie restriction in people with obesity. Calorie restriction was linked to lower overall food cravings (-0.246, 95% CI -0.490 to -0.001), as well as reduced cravings for sweet, high-fat, starchy, and fast foods. Heterogeneity across studies was explained by baseline weight, intervention type, duration, sample size, and participant sex.

Kahathuduwa CN, Binks M, Martin CK, et al. Obes Rev, 2017. PMID 28557246

2017 / Systematic review of randomized controlled trials

Evidence is limited to support nutritional supplements or diets for children with autism

Nineteen randomized trials evaluated dietary interventions or nutritional supplements in autism spectrum disorder. Omega-3 supplementation did not affect challenging behaviors and was linked to minimal harms (low strength of evidence). Although trials reported parent-rated improvements with gluten/casein-free diets and some improvements with methyl B12 or levocarnitine, data had insufficient strength of evidence to draw firm conclusions, with studies being small and short-term.

Sathe N, Andrews JC, McPheeters ML, et al. Pediatrics, 2017. PMID 28562286

2017 / Systematic review and meta-analysis of RCTs

Niacin therapy did not reduce mortality or cardiovascular events in people with or at risk of CVD and increased side effects.

A systematic review and meta-analysis of 23 RCTs involving 39,195 participants evaluated niacin monotherapy or add-on therapy (median dose 2 g/day, median duration 11.5 months). Niacin did not reduce overall mortality (RR 1.05, 95% CI 0.97 to 1.12), cardiovascular mortality (RR 1.02, 95% CI 0.93 to 1.12), non-cardiovascular mortality (RR 1.12, 95% CI 0.98 to 1.28), fatal or non-fatal myocardial infarctions (RR 0.93, 95% CI 0.87 to 1.00), or strokes (RR 0.95, 95% CI 0.74 to 1.22). Participants receiving niacin were significantly more likely to discontinue treatment due to side effects compared to control (RR 2.17, 95% CI 1.70 to 2.77).

Schandelmaier S, Briel M, Saccilotto R, et al. Cochrane Database Syst Rev, 2017. PMID 28616955

2017 / Systematic review and meta-analysis of randomized controlled trials

Calcium supplements modestly reduced recurrent adenomas, but trial sequential analysis found inconclusive evidence.

A meta-analysis of five randomized trials examined calcium supplementation in 2,234 patients with prior colorectal adenomas. Good-quality trials showed calcium reduced recurrent adenomas (RR 0.88, 95% CI 0.79-0.99), with stronger effects at doses of at least 1,600 mg per day (RR 0.74, 95% CI 0.56-0.97), but advanced adenomas were not significantly affected (RR 1.02, 95% CI 0.67-1.55). Hypercalcemia incidence increased (P = .0095), and GRADE certainty was rated low.

Veettil SK, Ching SM, Lim KG, et al. Medicine (Baltimore), 2017. PMID 28796047

2017 / Systematic review and meta-analysis of randomized controlled trials

B-vitamin supplements modestly reduced stroke risk but did not affect myocardial infarction or death.

An updated systematic review analyzed 15 randomized controlled trials with 71,422 participants evaluating vitamin B6, B9, or B12 supplements over 1 to 7.3 years. Compared to placebo, homocysteine-lowering interventions reduced stroke (4.3% vs. 5.1%; RR 0.90, 95% CI 0.82-0.99; 10 trials, n=44,224). However, no differences occurred for myocardial infarction (RR 1.02, 95% CI 0.95-1.10), all-cause mortality (RR 1.01, 95% CI 0.96-1.06), or serious adverse events (RR 1.07, 95% CI 1.00-1.14).

Martí-Carvajal AJ, Solà I, Lathyris D, et al. Cochrane Database Syst Rev, 2017. PMID 28816346